Medcura, Inc.

New Filing
CIK: 0001672180·Biotechnology·DELAWARE·Filed: Aug 16, 2022
Total Offering

$5,600,000

Amount Sold

$3,207,050

Investors

26

First Sale

Jul 29, 2022

Offering Details

Type
Equity, Debt, Option to Acquire, Security to be Acquired, Other: Convertible Promissory Notes; Common Stock or Series A-1 Preferred Stock underlying the convertible promissory notes.
Exemptions
Rule 506(b)
Entity Type
Corporation
Non-Accredited Investors
No

Related Persons

NameRole
Matthew Dowling
Related Person
Larry Tiffany
Related Person
Jim Buck
Related Person
Rich Vincent
Related Person

Company

Medcura, Inc.

5650 Rivertech Court

Riverdale, MD, 20737

(240) 684-8801

SEC Filing

0001567619-22-016358

View on SEC EDGAR

Want deeper insights?

Sign up for free to search all filings, track companies, and set up alerts.

Sign Up Free
Medcura, Inc. Form D Filing — $5,600,000 | FilingFlow